GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProText Mobility Inc (OTCPK:TXTM) » Definitions » Shiller PE Ratio

ProText Mobility (ProText Mobility) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2003. Start your Free Trial

What is ProText Mobility Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


ProText Mobility Shiller PE Ratio Historical Data

The historical data trend for ProText Mobility's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProText Mobility Shiller PE Ratio Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ProText Mobility's Shiller PE Ratio

For the Biotechnology subindustry, ProText Mobility's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Shiller PE Ratio falls into.



ProText Mobility Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ProText Mobility's E10 for the quarter that ended in Sep. 2014 is calculated as:

For example, ProText Mobility's adjusted earnings per share data for the three months ended in Sep. 2014 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=0/100.4278*100.4278
=0.000

Current CPI (Sep. 2014) = 100.4278.

ProText Mobility Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200412 -8.000 80.290 -10.007
200503 -8.000 81.555 -9.851
200506 -8.000 82.062 -9.790
200509 -8.000 83.876 -9.579
200512 -72.000 83.032 -87.085
200603 -24.000 84.298 -28.592
200606 -16.000 85.606 -18.770
200609 -24.000 85.606 -28.155
200612 -24.000 85.142 -28.309
200703 -24.000 86.640 -27.819
200706 -32.000 87.906 -36.558
200709 -24.000 87.964 -27.401
200712 -80.000 88.616 -90.663
200803 -16.000 90.090 -17.836
200806 -16.000 92.320 -17.405
200809 -8.000 92.307 -8.704
200812 -32.000 88.697 -36.232
200903 -8.000 89.744 -8.952
200906 -8.000 91.003 -8.829
200909 -32.000 91.120 -35.269
200912 -40.000 91.111 -44.090
201003 -56.000 91.821 -61.249
201006 -16.000 91.962 -17.473
201009 -8.000 92.162 -8.718
201012 -24.000 92.474 -26.064
201103 -8.000 94.283 -8.521
201106 0.000 95.235 0.000
201109 0.000 95.727 0.000
201112 -8.000 95.213 -8.438
201203 -8.000 96.783 -8.301
201206 0.000 96.819 0.000
201209 0.000 97.633 0.000
201212 -0.960 96.871 -0.995
201303 -1.043 98.209 -1.067
201306 -0.680 98.518 -0.693
201309 -0.620 98.790 -0.630
201312 -0.255 98.326 -0.260
201403 -0.112 99.695 -0.113
201406 -0.170 100.560 -0.170
201409 0.000 100.428 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ProText Mobility  (OTCPK:TXTM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


ProText Mobility Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of ProText Mobility's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ProText Mobility (ProText Mobility) Business Description

Traded in Other Exchanges
N/A
Address
One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD - Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.
Executives
Peter Sealey director 37400 CENTRAL COURT, NEWARK CA 94560

ProText Mobility (ProText Mobility) Headlines

From GuruFocus